URYPAB traded at 0.0248861 this Monday August 3rd, decreasing 0.0001280 or 0.51 percent since the previous trading session. Looking back, over the last four weeks, URYPAB lost 0.12 percent. Over the last 12 months, its price rose by 0.08 percent. Looking ahead, we forecast URYPAB to be priced at 0.0249248 by the end of this quarter and at 0.0252353 in one year, according to Trading Economics global macro models projections and analysts expectations.